| MicroRNA in disease regulation | Lifetime | 104 | IT 5 | 99.45 |
| Cancer-related molecular mechanisms research | Lifetime | 166 | IT 5 | 99.27 |
| Gastric Cancer Management and Outcomes | Lifetime | 151 | IT 9 | 99.53 |
| Esophageal Cancer Research and Treatment | Lifetime | 147 | IT 9 | 99.01 |
| Genetic factors in colorectal cancer | Lifetime | 210 | IT 11 | 99.04 |
| Circular RNAs in diseases | Lifetime | 170 | IT 8 | 98.66 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 423 | IT 28 | 98.91 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 260 | IT 22 | 98.79 |
| Cancer Genomics and Diagnostics | Lifetime | 628 | IT 13 | 98.84 |
| Colorectal Cancer Treatments and Studies | Lifetime | 430 | IT 38 | 98.71 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 497 | IT 47 | 98.23 |
| Neuroendocrine Tumor Research Advances | Lifetime | 903 | IT 94 | 97.32 |
| Cancer-related gene regulation | Lifetime | 948 | IT 15 | 95.90 |
| Colorectal and Anal Carcinomas | Lifetime | 792 | IT 41 | 95.72 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 976 | IT 56 | 95.65 |
| Genetic factors in colorectal cancer | 2021-2025 | 37 | IT 7 | 98.73 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 89 | IT 9 | 99.02 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 180 | IT 33 | 98.25 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 86 | IT 17 | 97.90 |
| Cancer Genomics and Diagnostics | 2021-2025 | 306 | IT 26 | 97.80 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 127 | IT 17 | 98.27 |
| Esophageal Cancer Research and Treatment | 2021-2025 | 155 | IT 5 | 96.54 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 209 | IT 12 | 94.17 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 374 | IT 74 | 92.82 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 363 | IT 31 | 91.87 |
| Lung Cancer Research Studies | 2021-2025 | 820 | IT 71 | 91.17 |
| Colorectal and Anal Carcinomas | 2021-2025 | 470 | IT 35 | 89.35 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 761 | IT 103 | 89.57 |
| Gastrointestinal disorders and treatments | 2021-2025 | 664 | IT 64 | 84.95 |
| HER2/EGFR in Cancer Research | 2021-2025 | 803 | IT 69 | 87.28 |
| Neuroblastoma Research and Treatments | 2021-2025 | 841 | IT 95 | 83.37 |
| Barrier Structure and Function Studies | 2021-2025 | 170 | IT 4 | 78.74 |
| Celiac Disease Research and Management | 2021-2025 | 788 | IT 155 | 66.17 |
| Chromatin Remodeling and Cancer | 2021-2025 | 998 | IT 52 | 52.75 |
